-
Mashup Score: 2Metabolomic Differences: Young Onset (yoCRC) vs. Average Onset (aoCRC) Colorectal Cancer - 7 month(s) ago
Listen as Dr. Kamath talks about the challenges associated with early detection, the evolving landscape of screening guidelines, potential contributing factors to the rise of yoCRC, and the role of metabolomics in unraveling the complexities of colorectal cancer.
Source: my.clevelandclinic.orgCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0
This nonrandomized controlled trial evaluates the safety and antitumor activity of anti-TIGIT antibody tiragolumab and its combination with atezolizumab in patients with advanced solid tumors.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Promising early signal of efficacy for tiragolumab (anti-TIGIT) and atezo in Esophageal cancer and NSCLC (many heavily pretreated): EC: 28% (5/18) ORR NSCLC: 46% (6/13) ORR https://t.co/w1dvNTgo8H https://t.co/j9VyiksvEm
-
-
Mashup Score: 7CME Program Takes Multidisciplinary Approach to Colorectal Cancer - 9 month(s) ago
Case-based course delves into latest treatment approaches
Source: consultqd.clevelandclinic.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
CME Program Takes Multidisciplinary Approach to Colorectal Cancer https://t.co/pOUAMXrYp7 via @CleClinicMD @aakonc @ClevelandClinic @ScottRSteeleMD
-
RT @LaurenSmrdel: .@ClevelandClinic CME Program Takes Multidisciplinary Approach to Colorectal Cancer https://t.co/aJLbECIDBW via @CleClini…
-
-
Mashup Score: 7
Oncologists and experts share the foods they eat for cancer prevention.
Source: www.today.comCategories: Hem/Oncs, Latest HeadlinesTweet-
If you're looking for ways to rejuvenate your breakfast routine, here are some fresh ideas! https://t.co/vSFwJMO2wX via @TodayShow
-
-
Mashup Score: 4FDA Grants Orphan Drug Designation to NXP800 for Cholangiocarcinoma - 9 month(s) ago
The FDA has granted an orphan drug designation to NXP800 for the treatment of patients with cholangiocarcinoma.
Source: www.onclive.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @OncLive: .@US_FDA Grants Orphan Drug Designation to NXP800 for Cholangiocarcinoma #oncology https://t.co/swPczqInVh
-
-
Mashup Score: 2Oncologists Share Healthy Breakfast Ideas To Reduce Cancer Risk - 9 month(s) ago
Oncologists and experts share the foods they eat for cancer prevention.
Source: www.today.comCategories: Latest Headlines, Oncologists1Tweet-
RT @Aiims1742: Weekend musings: What do oncologists eat for breakfast? https://t.co/XLhOIQk0ve @mcquadeMDLAc @SKamath_MD @Elizabeth_Comen w…
-
-
Mashup Score: 0A Decade of VeloSano - 9 month(s) ago
Listen as Mr. Kohl talks about the journey of VeloSano’s 10-year impact on advancing cancer research.
Source: my.clevelandclinic.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Proud to be fundraising and volunteering for the 10th VeloSano. So much quality cancer research has come from it and so much more to come! #CancerResearch https://t.co/ZNgUIA3ijS
-
-
Mashup Score: 4Clinical Implications of the HIMALAYA Study: Safety & Efficacy of Durvalumab & Tremelimumab Regimen in 1L Unresectable HCC - 10 month(s) ago
Clinical Implications of the HIMALAYA Study: Safety & Efficacy of Durvalumab & Tremelimumab Regimen in 1L Unresectable HCC
Source: www.vumedi.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Great to have 2 IO combos for 1L HCC, but which is best, STRIDE or Atezo/bev? Maybe we should use both in sequence. Hear my thoughts on @VuMedi https://t.co/jXwxVGk3DX via @VuMediHemOnc
-
-
Mashup Score: 12Prevention of venous thromboembolism in patients with cancer - 12 month(s) ago
Venous thromboembolism (VTE) is a major cause of both morbidity and mortality in patients with cancer. Venous thromboembolism, which includes both deep vein thrombosis and pulmonary embolism, affects a sizable portion of patients with malignancy and can have potentially life threatening complications. Accurate assessment of risk as well as diagnosis and treatment of this process is paramount to…
Source: The BMJCategories: Hem/Oncs, Latest HeadlinesTweet-
Our new multidisciplinary state-of-the-art paper now out in @bmj_latest led by @SakethGuntupal1 https://t.co/Ca7DIb9GLb
-
RT @aakonc: Our new multidisciplinary state-of-the-art paper now out in @bmj_latest led by @SakethGuntupal1 https://t.co/Ca7DIb9GLb
-
-
Mashup Score: 4
Unique molecular features found in young-onset disease
Source: Consult QDCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @SWexner: Foundational Research Yields Clues to Understanding Early-Onset Colorectal Cancer https://t.co/yDvqO2BbEP via @CleClinicMD gre…
-
Tune in to this week's episode of the @CleClinicMD, Cancer Advances #podcast where I discuss our #ASCO23 study exploring metabolomic differences between young-onset CRC and average-onset colorectal cancer #CleClinicCancer https://t.co/giNq8nXliT @aakonc @ThejusJay